Analystreport

Rigel Pharmaceuticals (NASDAQ:RIGL) had its price target raised by analysts at Cantor Fitzgerald from $32.00 to $38.00. They now have a "neutral" rating on the stock.

Rigel Pharmaceuticals, Inc.  (RIGL) 
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.rigel.com